{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:28:51Z","timestamp":1782624531527,"version":"3.54.5"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T00:00:00Z","timestamp":1741478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T00:00:00Z","timestamp":1741478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nanchang City High-level Scientific and Technological Innovation Talents \u201cDouble Hundred Plan\u201d","award":["Grant No. [2022]321"],"award-info":[{"award-number":["Grant No. [2022]321"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91883-3","type":"journal-article","created":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T11:29:16Z","timestamp":1741519756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lacidophilin tablets relieve irritable bowel syndrome in rats by regulating gut microbiota dysbiosis and intestinal inflammation"],"prefix":"10.1038","volume":"15","author":[{"given":"Huiqun","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,9]]},"reference":[{"key":"91883_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber, A. D. et al. Worldwide prevalence and burden of functional Gastrointestinal disorders, results of Rome foundation global study. Gastroenterology 160, 99\u2013114. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.014 (2021).","journal-title":"Gastroenterology"},{"key":"91883_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jgr.2021.03.008","volume":"45","author":"S Yu","year":"2021","unstructured":"Yu, S., Chun, E., Ji, Y., Lee, Y. J. & Jin, M. Effects of red ginseng on gut, microbiota, and brain in a mouse model of post-infectious irritable bowel syndrome. J. Ginseng Res. 45, 706\u2013716. https:\/\/doi.org\/10.1016\/j.jgr.2021.03.008 (2021).","journal-title":"J. Ginseng Res."},{"key":"91883_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/PSY.0000000000000161","volume":"77","author":"KA Janssens","year":"2015","unstructured":"Janssens, K. A., Zijlema, W. L., Joustra, M. L. & Rosmalen, J. G. Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: results from the lifelines cohort study. Psychosom. Med. 77, 449\u2013457. https:\/\/doi.org\/10.1097\/PSY.0000000000000161 (2015).","journal-title":"Psychosom. Med."},{"key":"91883_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.gastro.2022.04.016","volume":"163","author":"L Chang","year":"2022","unstructured":"Chang, L. et al. AGA clinical practice guideline on the Pharmacological management of irritable bowel syndrome with constipation. Gastroenterology 163, 118\u2013136. https:\/\/doi.org\/10.1053\/j.gastro.2022.04.016 (2022).","journal-title":"Gastroenterology"},{"key":"91883_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41575-020-00385-2","volume":"18","author":"B Niesler","year":"2021","unstructured":"Niesler, B., Kuerten, S., Demir, I. E. & Schafer, K. H. Disorders of the enteric nervous system - a holistic view. Nat. Rev. Gastroenterol. Hepatol. 18, 393\u2013410. https:\/\/doi.org\/10.1038\/s41575-020-00385-2 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"91883_CR6","doi-asserted-by":"publisher","first-page":"1039804","DOI":"10.3389\/fphys.2022.1039804","volume":"13","author":"Z Zhuang","year":"2022","unstructured":"Zhuang, Z., Huang, C., Zhang, Y. & Lv, B. Effects of Massa medicata fermentata on the intestinal pathogenic flagella bacteria and visceral hypersensitivity in rats with irritable bowel syndrome. Front. Physiol. 13, 1039804. https:\/\/doi.org\/10.3389\/fphys.2022.1039804 (2022).","journal-title":"Front. Physiol."},{"key":"91883_CR7","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3390\/nu13062112","volume":"13","author":"E Simon","year":"2021","unstructured":"Simon, E., Calinoiu, L. F., Mitrea, L. & Vodnar, D. C. Probiotics, prebiotics, and synbiotics: implications and beneficial effects against irritable bowel syndrome. Nutrients 13, 2112\u20132139. https:\/\/doi.org\/10.3390\/nu13062112 (2021).","journal-title":"Nutrients"},{"key":"91883_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5056\/jnm16220","volume":"23","author":"C Lee","year":"2017","unstructured":"Lee, C. et al. The increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: systematic review and meta-analysis. J. Neurogastroenterol Motil. 23, 349\u2013362. https:\/\/doi.org\/10.5056\/jnm16220 (2017).","journal-title":"J. Neurogastroenterol Motil."},{"key":"91883_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00394-022-02958-0","volume":"62","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines. Eur. J. Nutr. 62, 139\u2013155. https:\/\/doi.org\/10.1007\/s00394-022-02958-0 (2023).","journal-title":"Eur. J. Nutr."},{"key":"91883_CR10","doi-asserted-by":"publisher","first-page":"112153","DOI":"10.1016\/j.jep.2019.112153","volume":"245","author":"TA Thumann","year":"2019","unstructured":"Thumann, T. A., Pferschy-Wenzig, E. M., Moissl-Eichinger, C. & Bauer, R. The role of gut microbiota for the activity of medicinal plants traditionally used in the European union for Gastrointestinal disorders. J. Ethnopharmacol. 245, 112153. https:\/\/doi.org\/10.1016\/j.jep.2019.112153 (2019).","journal-title":"J. Ethnopharmacol."},{"key":"91883_CR11","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.3390\/jcm12072558","volume":"12","author":"SD Shaikh","year":"2023","unstructured":"Shaikh, S. D., Sun, N., Canakis, A., Park, W. Y. & Weber, H. C. Irritable bowel syndrome and the gut microbiome: a comprehensive review. J. Clin. Med. 12, 2558\u20132580. https:\/\/doi.org\/10.3390\/jcm12072558 (2023).","journal-title":"J. Clin. Med."},{"key":"91883_CR12","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala, S. M. et al. Role of the normal gut microbiota. World J. Gastroenterol. 21, 8787\u20138803. https:\/\/doi.org\/10.3748\/wjg.v21.i29.8787 (2015).","journal-title":"World J. Gastroenterol."},{"key":"91883_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mib.2016.10.003","volume":"35","author":"M Levy","year":"2017","unstructured":"Levy, M., Blacher, E. & Elinav, E. Microbiome, metabolites and host immunity. Curr. Opin. Microbiol. 35, 8\u201315. https:\/\/doi.org\/10.1016\/j.mib.2016.10.003 (2017).","journal-title":"Curr. Opin. Microbiol."},{"key":"91883_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1152\/ajpgi.00338.2016","volume":"312","author":"Y Bhattarai","year":"2017","unstructured":"Bhattarai, Y., Muniz Pedrogo, D. A. & Kashyap, P. C. Irritable bowel syndrome: a gut microbiota-related disorder? Am. J. Physiol. Gastrointest. Liver Physiol. 312, 52\u201362. https:\/\/doi.org\/10.1152\/ajpgi.00338.2016 (2017).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"91883_CR15","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1007\/s00253-021-11264-4","volume":"105","author":"P Sciavilla","year":"2021","unstructured":"Sciavilla, P. et al. Gut microbiota profiles and characterization of cultivable fungal isolates in IBS patients. Appl. Microbiol. Biotechnol. 105, 3277\u20133288. https:\/\/doi.org\/10.1007\/s00253-021-11264-4 (2021).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"91883_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","volume":"152","author":"J Tap","year":"2017","unstructured":"Tap, J. et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology 152, 111\u2013123. https:\/\/doi.org\/10.1053\/j.gastro.2016.09.049 (2017).","journal-title":"Gastroenterology"},{"key":"91883_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.amjms.2016.09.014","volume":"353","author":"T Yu","year":"2017","unstructured":"Yu, T. et al. Effects of prebiotics and synbiotics on functional constipation. Am. J. Med. Sci. 353, 282\u2013292. https:\/\/doi.org\/10.1016\/j.amjms.2016.09.014 (2017).","journal-title":"Am. J. Med. Sci."},{"key":"91883_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/nmo.12544","volume":"27","author":"CH Choi","year":"2015","unstructured":"Choi, C. H. et al. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. Neurogastroenterol Motil. 27, 705\u2013716. https:\/\/doi.org\/10.1111\/nmo.12544 (2015).","journal-title":"Neurogastroenterol Motil."},{"key":"91883_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/nu15020291","volume":"15","author":"L Ma","year":"2023","unstructured":"Ma, L., Tu, H. & Chen, T. Postbiotics in human health: a narrative review. Nutrients 15, 291\u2013308. https:\/\/doi.org\/10.3390\/nu15020291 (2023).","journal-title":"Nutrients"},{"key":"91883_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen, S. et al. The international scientific association of probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat. Rev. Gastroenterol. Hepatol. 18, 649\u2013667. https:\/\/doi.org\/10.1038\/s41575-021-00440-6 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"91883_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tifs.2018.03.009","volume":"75","author":"JE Aguilar-Toal\u00e1","year":"2018","unstructured":"Aguilar-Toal\u00e1, J. E. et al. Postbiotics: an evolving term within the functional foods field. Trends Food Sci. Technol. 75, 105\u2013114. https:\/\/doi.org\/10.1016\/j.tifs.2018.03.009 (2018).","journal-title":"Trends Food Sci. Technol."},{"key":"91883_CR22","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/nu12082189","volume":"12","author":"J Zolkiewicz","year":"2020","unstructured":"Zolkiewicz, J., Marzec, A., Ruszczynski, M. & Feleszko, W. Postbiotics-a step beyond pre- and probiotics. Nutrients 12, 2189\u20132206. https:\/\/doi.org\/10.3390\/nu12082189 (2020).","journal-title":"Nutrients"},{"key":"91883_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/mco2.420","volume":"4","author":"J Ji","year":"2023","unstructured":"Ji, J., Jin, W., Liu, S. J., Jiao, Z. & Li, X. Probiotics, prebiotics, and postbiotics in health and disease. MedComm (2020). 4, 420\u2013443. https:\/\/doi.org\/10.1002\/mco2.420 (2023).","journal-title":"MedComm (2020)"},{"key":"91883_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.19827\/j.issn1001-2230.2020.08.013","volume":"48","author":"XJ Ma","year":"2020","unstructured":"Ma, X. J. et al. Analysis and study of organic acids in Lactobacillin material. China Dairy. Ind. 48, 53\u201356. https:\/\/doi.org\/10.19827\/j.issn1001-2230.2020.08.013 (2020).","journal-title":"China Dairy. Ind."},{"key":"91883_CR25","doi-asserted-by":"publisher","unstructured":"Zhan, Y. et al. Effects of lacidophilin in a mouse model of low-grade colitis and nonalcoholic fatty liver disease. Food Bioscience. 60 https:\/\/doi.org\/10.1016\/j.fbio.2024.104469 (2024).","DOI":"10.1016\/j.fbio.2024.104469"},{"key":"91883_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.19827\/j.issn1001-2230.2021.08.001","volume":"49","author":"Y Zhan","year":"2021","unstructured":"Zhan, Y. et al. Effects of lactobacillus tablets on gut microbiota in antibiotic-associated diar-rhea model mice. China Dairy. Ind. 49, 4\u201310. https:\/\/doi.org\/10.19827\/j.issn1001-2230.2021.08.001 (2021).","journal-title":"China Dairy. Ind."},{"key":"91883_CR27","doi-asserted-by":"publisher","first-page":"729346","DOI":"10.3389\/fcimb.2021.729346","volume":"11","author":"L Xiao","year":"2021","unstructured":"Xiao, L., Liu, Q., Luo, M. & Xiong, L. Gut microbiota-derived metabolites in irritable bowel syndrome. Front. Cell. Infect. Microbiol. 11, 729346. https:\/\/doi.org\/10.3389\/fcimb.2021.729346 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"91883_CR28","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1136\/gutjnl-2020-320919","volume":"69","author":"IB Jeffery","year":"2020","unstructured":"Jeffery, I. B., O\u2019Herlihy, E. & Shanahan, F. PW, O. T. Microbiome alterations in IBS. Gut 69, 2263\u20132264. https:\/\/doi.org\/10.1136\/gutjnl-2020-320919 (2020).","journal-title":"Gut"},{"key":"91883_CR29","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00394-020-02437-4","volume":"60","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome. Eur. J. Nutr. 60, 2553\u20132565. https:\/\/doi.org\/10.1007\/s00394-020-02437-4 (2021).","journal-title":"Eur. J. Nutr."},{"key":"91883_CR30","doi-asserted-by":"publisher","first-page":"746585","DOI":"10.3389\/fimmu.2021.746585","volume":"12","author":"B Yang","year":"2021","unstructured":"Yang, B. et al. Lactobacillus plantarum CCFM1143 alleviates chronic diarrhea via inflammation regulation and gut microbiota modulation: a double-blind, randomized, placebo-controlled study. Front. Immunol. 12, 746585. https:\/\/doi.org\/10.3389\/fimmu.2021.746585 (2021).","journal-title":"Front. Immunol."},{"key":"91883_CR31","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3390\/nu11081859","volume":"11","author":"K Nishida","year":"2019","unstructured":"Nishida, K., Sawada, D., Kuwano, Y., Tanaka, H. & Rokutan, K. Health benefits of lactobacillus gasseri CP2305 tablets in young adults exposed to chronic stress: a randomized, double-blind, placebo-controlled study. Nutrients 11, 1859\u20131873. https:\/\/doi.org\/10.3390\/nu11081859 (2019).","journal-title":"Nutrients"},{"key":"91883_CR32","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/nu12041159","volume":"12","author":"ED Lewis","year":"2020","unstructured":"Lewis, E. D. et al. Efficacy of lactobacillus paracasei HA-196 and bifidobacterium longum R0175 in alleviating symptoms of irritable bowel syndrome (IBS): a randomized, placebo-controlled study. Nutrients 12, 1159\u20131178. https:\/\/doi.org\/10.3390\/nu12041159 (2020).","journal-title":"Nutrients"},{"key":"91883_CR33","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S2468-1253(20)30056-X","volume":"5","author":"V Andresen","year":"2020","unstructured":"Andresen, V., Gschossmann, J. & Layer, P. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lancet Gastroenterol. Hepatol. 5, 658\u2013666. https:\/\/doi.org\/10.1016\/S2468-1253(20)30056-X (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"91883_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/ajg.2009.25","volume":"104","author":"DM Brenner","year":"2009","unstructured":"Brenner, D. M., Moeller, M. J., Chey, W. D. & Schoenfeld, P. S. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am. J. Gastroenterol. 104, 1033\u20131050. https:\/\/doi.org\/10.1038\/ajg.2009.25 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"91883_CR35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12906-019-2528-2","volume":"19","author":"LO Chuah","year":"2019","unstructured":"Chuah, L. O. et al. Postbiotic metabolites produced by Lactobacillus plantarum strains exert selective cytotoxicity effects on cancer cells. BMC Complement. Altern. Med. 19, 114\u2013126. https:\/\/doi.org\/10.1186\/s12906-019-2528-2 (2019).","journal-title":"BMC Complement. Altern. Med."},{"key":"91883_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2982.2006.00875.x","volume":"19","author":"F Azpiroz","year":"2007","unstructured":"Azpiroz, F. et al. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 19, 62\u201388. https:\/\/doi.org\/10.1111\/j.1365-2982.2006.00875.x (2007).","journal-title":"Neurogastroenterol Motil."},{"key":"91883_CR37","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrgastro.2014.103","volume":"11","author":"SM Brierley","year":"2014","unstructured":"Brierley, S. M. & Linden, D. R. Neuroplasticity and dysfunction after Gastrointestinal inflammation. Nat. Rev. Gastroenterol. Hepatol. 11, 611\u2013627. https:\/\/doi.org\/10.1038\/nrgastro.2014.103 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"91883_CR38","doi-asserted-by":"publisher","unstructured":"Wei, Y. et al. Baizhu Shaoyao Decoction restores the intestinal barrier and brain\u2013gut axis balance to alleviate diarrhea-predominant irritable bowel syndrome via FoxO1\/FoxO3a. Phytomedicine 122 https:\/\/doi.org\/10.1016\/j.phymed.2023.155163 (2024).","DOI":"10.1016\/j.phymed.2023.155163"},{"key":"91883_CR39","doi-asserted-by":"publisher","unstructured":"Ouyang, L. et al. A multi-omics study reveals the therapeutic effect of Linderae Radix water extract on irritable bowel syndrome (IBS-D). J. Ethnopharmacol. 328 https:\/\/doi.org\/10.1016\/j.jep.2024.118050 (2024).","DOI":"10.1016\/j.jep.2024.118050"},{"key":"91883_CR40","doi-asserted-by":"publisher","first-page":"14126","DOI":"10.3748\/wjg.v20.i39.14126","volume":"20","author":"HY Qin","year":"2014","unstructured":"Qin, H. Y., Cheng, C. W., Tang, X. D. & Bian, Z. X. Impact of psychological stress on irritable bowel syndrome. World J. Gastroenterol. 20, 14126\u201314131. https:\/\/doi.org\/10.3748\/wjg.v20.i39.14126 (2014).","journal-title":"World J. Gastroenterol."},{"key":"91883_CR41","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00213-024-06713-7","volume":"241","author":"M Sharma","year":"2024","unstructured":"Sharma, M. et al. Efficacy of Nigella sativa seed oil against psychophysical stress induced irritable bowel syndrome and anxiety-like symptoms in Wistar rats. Psychopharmacology 241, 2609\u20132626. https:\/\/doi.org\/10.1007\/s00213-024-06713-7 (2024).","journal-title":"Psychopharmacology"},{"key":"91883_CR42","doi-asserted-by":"publisher","first-page":"110694","DOI":"10.1016\/j.jpsychores.2021.110694","volume":"153","author":"SJ Schaper","year":"2022","unstructured":"Schaper, S. J. & Stengel, A. Emotional stress responsivity of patients with IBS - a systematic review. J. Psychosom. Res. 153, 110694. https:\/\/doi.org\/10.1016\/j.jpsychores.2021.110694 (2022).","journal-title":"J. Psychosom. Res."},{"key":"91883_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrgastro.2012.57","volume":"9","author":"E Deloose","year":"2012","unstructured":"Deloose, E., Janssen, P., Depoortere, I. & Tack, J. The migrating motor complex: control mechanisms and its role in health and disease. Nat. Rev. Gastroenterol. Hepatol. 9, 271\u2013285. https:\/\/doi.org\/10.1038\/nrgastro.2012.57 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"91883_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1365-2982.2011.01673.x","volume":"23","author":"KM Vincent","year":"2011","unstructured":"Vincent, K. M., Sharp, J. W. & Raybould, H. E. Intestinal glucose-induced calcium-calmodulin kinase signaling in the gut-brain axis in awake rats. Neurogastroenterol Motil. 23, 282\u2013293. https:\/\/doi.org\/10.1111\/j.1365-2982.2011.01673.x (2011).","journal-title":"Neurogastroenterol Motil."},{"key":"91883_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2147\/JIR.S174982","volume":"11","author":"QX Ng","year":"2018","unstructured":"Ng, Q. X., Soh, A. Y. S., Loke, W., Lim, D. Y. & Yeo, W. S. The role of inflammation in irritable bowel syndrome (IBS). J. Inflamm. Res. 11, 345\u2013349. https:\/\/doi.org\/10.2147\/JIR.S174982 (2018).","journal-title":"J. Inflamm. Res."},{"key":"91883_CR46","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41577-022-00713-4","volume":"22","author":"J Aguilera-Lizarraga","year":"2022","unstructured":"Aguilera-Lizarraga, J., Hussein, H. & Boeckxstaens, G. E. Publisher correction: immune activation in irritable bowel syndrome: what is the evidence? Nat. Rev. Immunol. 22, 332\u2013333. https:\/\/doi.org\/10.1038\/s41577-022-00713-4 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"91883_CR47","doi-asserted-by":"publisher","first-page":"718356","DOI":"10.3389\/fnut.2021.718356","volume":"8","author":"G Barbara","year":"2021","unstructured":"Barbara, G. et al. Inflammatory and microbiota-related regulation of the intestinal epithelial barrier. Front. Nutr. 8, 718356. https:\/\/doi.org\/10.3389\/fnut.2021.718356 (2021).","journal-title":"Front. Nutr."},{"key":"91883_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrgastro.2010.4","volume":"7","author":"L Ohman","year":"2010","unstructured":"Ohman, L. & Simren, M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat. Rev. Gastroenterol. Hepatol. 7, 163\u2013173. https:\/\/doi.org\/10.1038\/nrgastro.2010.4 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"91883_CR49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00535-023-01997-6","volume":"58","author":"G Dothel","year":"2023","unstructured":"Dothel, G. et al. New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics. J. Gastroenterol. 58, 605\u2013621. https:\/\/doi.org\/10.1007\/s00535-023-01997-6 (2023).","journal-title":"J. Gastroenterol."},{"key":"91883_CR50","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/gutjnl-2022-328515","volume":"72","author":"M Camilleri","year":"2023","unstructured":"Camilleri, M. & Boeckxstaens, G. Irritable bowel syndrome: treatment based on pathophysiology and biomarkers. Gut 72, 590\u2013599. https:\/\/doi.org\/10.1136\/gutjnl-2022-328515 (2023).","journal-title":"Gut"},{"key":"91883_CR51","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cell.2020.10.040","volume":"183","author":"RAT Mars","year":"2020","unstructured":"Mars, R. A. T. et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. Cell 183, 1137\u20131140. https:\/\/doi.org\/10.1016\/j.cell.2020.10.040 (2020).","journal-title":"Cell"},{"key":"91883_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","volume":"17","author":"CJ Black","year":"2020","unstructured":"Black, C. J. & Ford, A. C. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat. Rev. Gastroenterol. Hepatol. 17, 473\u2013486. https:\/\/doi.org\/10.1038\/s41575-020-0286-8 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"91883_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.chom.2022.11.006","volume":"31","author":"L Zhai","year":"2023","unstructured":"Zhai, L. et al. Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis. Cell. Host Microbe. 31, 33\u201344. https:\/\/doi.org\/10.1016\/j.chom.2022.11.006 (2023).","journal-title":"Cell. Host Microbe"},{"key":"91883_CR54","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1053\/j.gastro.2022.02.016","volume":"162","author":"J Gao","year":"2022","unstructured":"Gao, J., Xiong, T., Grabauskas, G. & Owyang, C. Mucosal serotonin reuptake transporter expression in irritable bowel syndrome is modulated by gut microbiota via mast cell-prostaglandin E2. Gastroenterology 162, 1962\u20131974. https:\/\/doi.org\/10.1053\/j.gastro.2022.02.016 (2022).","journal-title":"Gastroenterology"},{"key":"91883_CR55","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/apt.15001","volume":"48","author":"AC Ford","year":"2018","unstructured":"Ford, A. C., Harris, L. A., Lacy, B. E., Quigley, E. M. M. & Moayyedi, P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment. Pharmacol. Ther. 48, 1044\u20131060. https:\/\/doi.org\/10.1111\/apt.15001 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"91883_CR56","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.clnu.2023.03.019","volume":"42","author":"G Konstantis","year":"2023","unstructured":"Konstantis, G. et al. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: a systematic review and meta-analysis of randomised clinical trials using ROME IV criteria. Clin. Nutr. 42, 800\u2013809. https:\/\/doi.org\/10.1016\/j.clnu.2023.03.019 (2023).","journal-title":"Clin. Nutr."},{"key":"91883_CR57","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1053\/j.gastro.2023.07.018","volume":"165","author":"VC Goodoory","year":"2023","unstructured":"Goodoory, V. C. et al. Efficacy of probiotics in irritable bowel syndrome: systematic review and meta-analysis. Gastroenterology 165, 1206\u20131218. https:\/\/doi.org\/10.1053\/j.gastro.2023.07.018 (2023).","journal-title":"Gastroenterology"},{"key":"91883_CR58","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.3390\/ijms18122645","volume":"18","author":"L Costantini","year":"2017","unstructured":"Costantini, L., Molinari, R., Farinon, B. & Merendino, N. Impact of omega-3 fatty acids on the gut microbiota. Int. J. Mol. Sci. 18, 2645\u20132663. https:\/\/doi.org\/10.3390\/ijms18122645 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"91883_CR59","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1039\/d0fo02375b","volume":"12","author":"Q Kong","year":"2021","unstructured":"Kong, Q. et al. Daily intake of Lactobacillus alleviates autistic-like behaviors by ameliorating the 5-hydroxytryptamine metabolic disorder in VPA-treated rats during weaning and sexual maturation. Food Funct. 12, 2591\u20132604. https:\/\/doi.org\/10.1039\/d0fo02375b (2021).","journal-title":"Food Funct."},{"key":"91883_CR60","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1136\/gutjnl-2016-313425","volume":"66","author":"M Camilleri","year":"2017","unstructured":"Camilleri, M. & Boeckxstaens, G. Dietary and Pharmacological treatment of abdominal pain in IBS. Gut 66, 966\u2013974. https:\/\/doi.org\/10.1136\/gutjnl-2016-313425 (2017).","journal-title":"Gut"},{"key":"91883_CR61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmi.2015.09.026","volume":"22","author":"M Rasmussen","year":"2016","unstructured":"Rasmussen, M. Aerococcus: an increasingly acknowledged human pathogen. Clin. Microbiol. Infect. 22, 22\u201327. https:\/\/doi.org\/10.1016\/j.cmi.2015.09.026 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"91883_CR62","doi-asserted-by":"publisher","first-page":"10096","DOI":"10.1007\/s10096-023-04704-8","volume":"23","author":"RM Antonello","year":"2023","unstructured":"Antonello, R. M., Riccardi, N., Saderi, L. & Sotgiu, G. Synergistic properties of linezolid against Enterococcus spp. Isolates: a systematic review from in vitro studies. Eur. J. Clin. Microbiol. Infect. Dis. 23, 10096. https:\/\/doi.org\/10.1007\/s10096-023-04704-8 (2023).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"91883_CR63","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1039\/d2np00084a","volume":"40","author":"G Kumar","year":"2023","unstructured":"Kumar, G. & Engle, K. Natural products acting against S. aureus through membrane and cell wall disruption. Nat. Prod. Rep. 40, 1608\u20131646. https:\/\/doi.org\/10.1039\/d2np00084a (2023).","journal-title":"Nat. Prod. Rep."},{"key":"91883_CR64","doi-asserted-by":"publisher","first-page":"e00012","DOI":"10.14309\/ctg.0000000000000012","volume":"10","author":"R Duan","year":"2019","unstructured":"Duan, R., Zhu, S., Wang, B. & Duan, L. Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA-targeted sequencing: a systematic review. Clin. Transl Gastroenterol. 10, e00012. https:\/\/doi.org\/10.14309\/ctg.0000000000000012 (2019).","journal-title":"Clin. Transl Gastroenterol."},{"key":"91883_CR65","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1136\/gutjnl-2013-305994","volume":"63","author":"J Jalanka-Tuovinen","year":"2014","unstructured":"Jalanka-Tuovinen, J. et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 63, 1737\u20131745. https:\/\/doi.org\/10.1136\/gutjnl-2013-305994 (2014).","journal-title":"Gut"},{"key":"91883_CR66","doi-asserted-by":"crossref","unstructured":"Yang, N. et al. Effects of lacidophilin tablets, yogurt, and bifid triple viable capsules on the gut microbiota of mice with antibiotic-associated diarrhea. Can. J. Infect. Dis. Med. Microbiol. 2022 (6521793). https:\/\/doi.org\/10.1155\/2022\/6521793 (2022).","DOI":"10.1155\/2022\/6521793"},{"key":"91883_CR67","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3390\/microorganisms11102369","volume":"11","author":"M Napolitano","year":"2023","unstructured":"Napolitano, M. et al. Gut dysbiosis in irritable bowel syndrome: a narrative review on correlation with disease subtypes and novel therapeutic implications. Microorganisms 11, 2369\u20132400. https:\/\/doi.org\/10.3390\/microorganisms11102369 (2023).","journal-title":"Microorganisms"},{"key":"91883_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12876-021-01613-y","volume":"21","author":"IF Shaidullov","year":"2021","unstructured":"Shaidullov, I. F. et al. Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome. BMC Gastroenterol. 21, 37\u201349. https:\/\/doi.org\/10.1186\/s12876-021-01613-y (2021).","journal-title":"BMC Gastroenterol."},{"key":"91883_CR69","doi-asserted-by":"publisher","first-page":"781","DOI":"10.62347\/vzjl1218","volume":"16","author":"XY Han","year":"2024","unstructured":"Han, X. Y. Electroacupuncture protects the intestinal mucosal barrier in diarrhea-predominant irritable bowel syndrome rats by regulating the MCs\/Tryptase\/PAR-2\/MLCK pathway. Am. J. Translational Res. 16, 781\u2013793. https:\/\/doi.org\/10.62347\/vzjl1218 (2024).","journal-title":"Am. J. Translational Res."},{"key":"91883_CR70","doi-asserted-by":"publisher","unstructured":"Song, S. et al. Effects of PAR2 gene knockout on visceral sensitivity, stress behaviors, and colonic electrical activities in irritable bowel syndrome. Discov. Med. 35 https:\/\/doi.org\/10.24976\/Discov.Med.202335178.75 (2023).","DOI":"10.24976\/Discov.Med.202335178.75"},{"key":"91883_CR71","doi-asserted-by":"publisher","first-page":"e16613","DOI":"10.1016\/j.heliyon.2023.e16613","volume":"9","author":"D Zhou","year":"2023","unstructured":"Zhou, D. et al. Protective effects of Liupao tea against high-fat diet\/cold exposure-induced irritable bowel syndrome in rats. Heliyon 9, e16613. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16613 (2023).","journal-title":"Heliyon"},{"key":"91883_CR72","doi-asserted-by":"publisher","first-page":"1059594","DOI":"10.3389\/fnbeh.2022.1059594","volume":"16","author":"J Xia","year":"2022","unstructured":"Xia, J. et al. The comparison of sex differences in depression-like behaviors and neuroinflammatory changes in a rat model of depression induced by chronic stress. Front. Behav. Neurosci. 16, 1059594. https:\/\/doi.org\/10.3389\/fnbeh.2022.1059594 (2022).","journal-title":"Front. Behav. Neurosci."},{"key":"91883_CR73","doi-asserted-by":"publisher","unstructured":"Wang, L. et al. Transdermal administration of volatile oil from citrus aurantium-rhizoma atractylodis macrocephalae alleviates constipation in rats by altering host metabolome and intestinal microbiota composition. Oxid Med Cell Longev 9965334, (2022). https:\/\/doi.org\/10.1155\/2022\/9965334 (2022).","DOI":"10.1155\/2022\/9965334"},{"key":"91883_CR74","doi-asserted-by":"publisher","unstructured":"Xiong, T. et al. Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS\/TLR4\/NF-\u03baB pathway. J. Ethnopharmacol. 289 https:\/\/doi.org\/10.1016\/j.jep.2022.115001 (2022).","DOI":"10.1016\/j.jep.2022.115001"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91883-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91883-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91883-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T11:29:23Z","timestamp":1741519763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91883-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,9]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91883"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91883-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,9]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments in this study were approved by the experimental animal ethics committee of Jiangzhong Pharmaceutical Co., Ltd. (No. 20220415). All procedures were carried out according to Guidelines for the Care and Use of Laboratory Animals and the Chinese Legislation on Laboratory Animals. The reporting in this study follows the recommendations in the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical declarations"}}],"article-number":"8151"}}